Delivery Order SPE2DB22D2211-SPE2DB25FSERJ
- Not listed
- The Defense Logistics Agency awarded a $69,112.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp for BIMZELX 160 mg/ml auto-injectors, with an ultimate completion date of August 5, 2025. This competitive award, which was not set-aside, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The product will be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for BIMZELX 160 mg/mL auto-injectors, a specialty pharmaceutical product, with a ceiling value of $26,727.10. This firm fixed-price delivery order, awarded on August 27, 2025, with an ultimate completion date of August 28, 2025, represents a non-competitive set-aside award. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $11,394.41 firm fixed-price delivery order to AmerisourceBergen Drug Corp for BIMZELX 160 mg/ml auto-injector product, with an ultimate completion date of August 6, 2025. This competitively awarded contract, with no set-aside designation, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $35,057.06 to AmerisourceBergen Drug Corp for BIMZELX 320 mg/2 mL auto-injector pharmaceutical products. This firm fixed-price, competitively awarded delivery order was issued on September 12, 2025, with an ultimate completion date of September 15, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating it was competed among...
- The Defense Logistics Agency awarded a $45,373.18 firm fixed-price delivery order to AmerisourceBergen Drug Corp for BIMZELX 160 mg/ml auto-injectors, with a completion date of July 22, 2025. This non-set-aside contract represents a direct procurement of a specialized pharmaceutical product to support federal healthcare needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for military and veteran...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at approximately $35K to AmerisourceBergen Drug Corp for BIMZELX 320 mg/2 mL auto-injector pharmaceutical products. This non-set-aside, competitively awarded contract features firm fixed pricing and is scheduled for completion by September 15, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in Conshohocken....
- The Defense Logistics Agency awarded a delivery order valued at $9,783.88 to AmerisourceBergen Drug Corp for BIMZELX 160 mg/ml autoinjector on August 20, 2025, with an ultimate completion date of August 21, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location. The contract represents a single shipment of this specialty...
- The Defense Logistics Agency awarded a $10,863.60 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of BIMZELX 160 mg/ml autoinjectors. The contract, which will be performed at the company's corporate office location in Conshohocken, Pennsylvania, represents a non-competitive delivery order without set-aside designation. This award is issued as a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $43,770.93 to AmerisourceBergen Drug Corp for the supply of BIMZELX 320 mg/2 mL auto-injector units. The contract, which was competitively awarded without set-aside restrictions, carries a firm fixed price structure and an ultimate completion date of August 18, 2025. Performance of this delivery order will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $10,250.68 to AmerisourceBergen Drug Corp for BIMZELX 160 mg/ml autoinjector on August 29, 2025, with completion expected by September 2, 2025. This competitively awarded, firm fixed-price contract involves pharmaceutical delivery to support federal medical procurement needs. The contract is classified as a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSERJDelivery Order
The Defense Logistics Agency awarded a $51,713.58 delivery order to AmerisourceBergen Drug Corp for BIMZELX 160 mg/ml auto-injectors, with completion scheduled for September 11, 2025. This firm fixed-price, competitively awarded contract represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The product will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, holds a significant $999,999,999.00 indefinite delivery contract with DLA Troop Support Medical (designated SPE2DX) through December 2026 that serves as the overarching vehicle for this delivery order. The company supplies a comprehensive range of pharmaceutical products and medical devices to support military and veteran healthcare systems worldwide, including specialty medications, vaccines, and medical supplies across multiple therapeutic domains. This delivery order for BIMZELX auto-injectors supports the Defense Health Agency and other government healthcare systems' pharmaceutical needs as part of DLA's broader medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $51.7k | 9/10/25 |